Colombo, "HBV-related HCC, clinical issues and therapy," Digestive and Liver Disease, vol. 43, supplement 1, pp. S32-S39, 2011.HBV-related HCC, clinical issues and therapy. Massimo Iavarone,Massimo Colombo. Digestive and Liver Disease . 2011...
Hepatitis B virus (HBV) is one of the major risk factors of hepatocellular carcinoma (HCC). Increasing evidence indicates that microRNA (miRNA)–mRNA axis is involved in HCC. However, a comprehensive miRNA–mRNA regulatory network in HBV-related HCC is still absent. This study aims to identify...
we transfected Flag-HBc into Huh-7 cells, and a series of experiments were conducted to determine the effect of colchicine on HBc overexpression on HCC progression. We found that colchicine significantly decreased the migration,
Chapter 3 Role of Anti-Viral Therapy on Hepatitis B Virus ( HBV )-Related Hepatocellular Carcinoma ( HCC )doi:10.5772/55551 C Chong,G Wong,V Wong,... 被引量: 0发表: 2013年 The Emerging Role of Ground Glass Hepatocytes and Hepatitis B Virus Pre-S Mutants in Anti-Viral Therapy and HBV...
(YTHDF2), plays a critical role in the HCC progression. However, the function and regulatory mechanisms of YTHDF2 in HBV-related HCC remain largely elusive. Here, we discovered that YTHDF2 O-GlcNAcylation was markedly increased upon HBV infection. O-GlcNAc transferase (OGT)-mediated O-...
In six patients with advanced HBV-HCC who received SCG101 at 5.0×107 ~ 1.0×108 TCR+ T cells/kg, the objective response rate (ORR) is 33%. All patients who achieved partial responses (PR) maintained remission for over 6 months, and one had complete remission of the target lesion and ...
Patients with hepatocellular carcinoma (HCC) have poor long-term survival following curative resection because of the high rate of tumor early recurrence. Little is known about the trajectory of genomic evolution from primary to early-recurrent HCC. In this study, we performed whole-genome sequencing...
Hepatocellular carcinoma (HCC) associated with Hepatitis B Virus (HBV) is one of the most severe malignancies in East Asia, where early diagnosis is crucial for improving patient prognosis. So we aim to identify effective early diagnostic model for HCC.#We enrolled 108 early-stage HCC patients ...
1. 本邦におけるB型慢性肝疾患からの肝発癌予測リスクスコアモデル (Japanese risk estimations of HBV-related HCC : JAB-HCCノの作成 [J] . 保坂哲, 也鈴木文孝, 小林正宏, 肝脏. 2015,第9期 机译:编写有关乙型肝炎的慢性乙型肝炎的日本风险评估:日本的慢性乙型肝炎的JAB-HCC编号 2. コモン...
“HBV-related HCC occurs in over 420,000 people every year worldwide and majority of advanced HCC patients relapse quickly after initial treatment. However, existing treatments are very limited especially on improving overall survival,” Tina Tingting Wang, COO and CMO of Lion TCR...